Seattle Genetics to Webcast Investor, Analyst Event at Hematology Meet

Seattle Genetics, Inc. (NASDAQ:SGEN) announced today that the company will webcast an investor and analyst event on Monday, December 3, 2018 during the 60th American Society of Hematology (ASH) Annual Meeting in San Diego, Calif. The program will feature the phase 3 ECHELON-2 trial as well as other key data from the meeting.

The webcast will begin at approximately 8:15 p.m. Pacific Time. The webcast will be available live and for replay from Seattle Genetics’ website at www.seattlegenetics.com in the Investors section.

https://www.biospace.com/article/releases/seattle-genetics-to-webcast-investor-and-analyst-event-at-the-60th-american-society-of-hematology-annual-meeting/